“It will be transformative in the way we treat pancreas cancer. It’s the biggest development we’ve had in pancreas cancer in decades,” said Andrew Ko, a medical oncologist specializing in gastrointestinal cancers at UCSF. “I’m so thankful for this as an advance for our patients.”
FDA approves new pancreatic cancer drug expected to usher in new era of treatment
The FDA has approved a life-extending treatment for advanced pancreatic cancer — the first such therapy to attack a genetic cause of the highly lethal malignancy.
statnews.com
